One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of March 12, 2014, Dr. Adams reported no financial interest relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
New York-Presbyterian Hospital, Weill Cornell Medical Center, 2000-2002
Chief Resident, Pediatrics – New York-Presbyterian Hospital, Weill Cornell Medical Center, 2002-2003
Hospital for Special Surgery, 2003-2006
Adams A, Onel KB, Lehman TJA. Inflammatory Myopathy and Celiac Disease. Pediatric Rheumatology Online Journal. 2005; 3(1).
Adams A, Kazim M, Lehman TJA. Treatment of Orbital Myositis with Adalimumab (Humira). The Journal of Rheumatology. 2005; 32(7): 1374-5.
Adams A, Lehman TJA. Update on the Pathogenesis and Treatment of Systemic Onset Juvenile Rheumatoid Arthritis. Current Opinion in Rheumatology. 2005; 17(5): 612-16.
Adams A, MacDermott EJ, Lehman TJA. Pharmacology of Lupus Nephritis in Children: A Recommended Treatment Approach. Drugs. 2006; 66(9): 1191-207.
For more publications, please see the PubMed listing.
Adams A. Last Minute Pediatrics – A Concise Review for the Specialty Boards. Associate Editor and Contributor. McGraw Hill, 2004.
Fabrizio LM, Adams A, Leff LR, Onel KB. "Development of an Innovative Pediatric Infusion Unit." American College of Rheumatology, AHRP - Poster Presentation, October, 2003.
Adams A, Barillas-Arias L, Angeles ST, Macderott EJ, Barinstein L, Lehman TJA. "Cyclophosphamide and Rituximab Combination Therapy for the Treatment of Juvenile-Onset Scleroderma: 6 Patient Case Series." Abstract #290, Poster Presentation. American College of Rheumatology, November, 2006.
Barillas-Arias L, Adams A, Angeles ST, MacDermott EJ, Barinstein L, Lehman TJA. "Combination of Rituximab and Cyclophosphamide for the Treatment of Childhood Onset Systemic Lupus Erythematosus." Abstract #1725, Poster Presentation. Amerivan College of Rheumatology, November, 2006.
Moorthy LN, Adams A, Onel K, Peterson M, Vazquez L, MacDermott E, Barillas L, Baratelli M, Barinstein L, Lehman T. "Celiac Disease and Pediatric Rheumatic Diseases – A Case Series." Poster Presentation. 3rd National Conference of Rheumatology Chapter, Indican Academy of Pediatrics. October, 2005.